Rare diseases
Investigational molecules
Locations
Back to Poland1 824 clinical trials in Warsaw, Poland across 33 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer's Disease over 72 weeks
PolandEvaluating sacituzumab tirumotecan alone or with pembrolizumab compared to standard treatment in untreated patients with metastatic triple-negative breast cancer with low PD-L1 expression
PolandLong-term safety and effectiveness study of CYB003 (deupsilocin besilate) with optional additional doses for people with Major Depressive Disorder
PolandStudy of XL092 and belzutifan combination therapy in people with clear cell kidney cancer who had disease return during or after immunotherapy treatment
PolandStudy of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies
PolandStudy of mRNA-4157 and Pembrolizumab for Patients with Metastatic Melanoma
PolandEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
PolandPolandStudy Comparing Golcadomide and Rituximab with Other Treatments for Patients with Relapsed or Refractory Follicular Lymphoma
PolandStudy of Long-Term Neurocognitive Outcomes in Children with Phenylketonuria Treated with Sepiapterin
PolandEffectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis
PolandVusolimogene Oderparepvec with Nivolumab for Advanced Melanoma Patients Whose Cancer Progressed After Previous Immunotherapy Treatments
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) prevention in older adults. Studies include evaluation of novel vaccine formulations and immune responses in various age groups.
Particular emphasis on vaccine development for adults aged 60 and older.
Comprehensive research on meningococcal vaccines across different age groups, from infants to toddlers. Studies evaluate safety profiles and immune responses to various vaccine formulations.
Focus on preventive healthcare through advanced vaccination strategies.
Studies investigating treatments for psoriasis and psoriatic arthritis, including novel biological therapies and their mechanisms of action.
Emphasis on moderate to severe cases requiring advanced therapeutic interventions.
Clinical research focusing on bladder cancer and innovative combination therapies. Studies evaluate treatment efficacy in early-stage non-muscle invasive cases.
Integration of targeted therapies with standard treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
